# CYCLOSPORINE
> **ANDA209064** · Abbreviated New Drug Application (Generic) · Sponsor: TWI PHARMS · Approved 2026-01-21
## Drug
- **FDA Application Number:** ANDA209064
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CYCLOSPORINE
- **Generic name:** CYCLOSPORINE
- **Active ingredients:** CYCLOSPORINE
- **Dosage form:** EMULSION
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** TWI PHARMS
- **Manufacturer:** Upsher-Smith Laboratories, LLC
- **First approval:** 2026-01-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209064)
---
*MORVS · CC0 1.0*